The above evidence implied that MELTF-AS1 has a negative regulatory effect on miR-1299, and MELTF-AS1 may serve as a biomarker of NSCLC and promote the progress of NSCLC. The gene discussed is MELTF; the disease is non-small cell lung carcinoma.